These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6837130)

  • 21. [Ergotism in heparin-dihydroergotamine therapy].
    Schneck HJ; Tempel G; Kramann B
    Dtsch Med Wochenschr; 1983 Mar; 108(10):397. PubMed ID: 6825582
    [No Abstract]   [Full Text] [Related]  

  • 22. Ergotism and heparin-dihydroergotamine prophylaxis.
    Krupp P; Majer M
    Lancet; 1982 Jun; 1(8284):1302. PubMed ID: 6123037
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevention of thromboembolism with heparin and dihydroergotamine in a trauma surgery patient sample--comparison of the effectiveness of different administration forms of dihydroergotamine].
    Schott G; Elsel W; Möckel G; Rothe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(19):973-6. PubMed ID: 1441633
    [No Abstract]   [Full Text] [Related]  

  • 24. [5 years' general drug prevention of thromboembolism in general surgery. Comparison of personal experiences with results from the literature].
    Voigt J; Lennert K; Hedderich J
    Fortschr Med; 1984 May; 102(20):562-4. PubMed ID: 6735335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible vasospasm in association with the use of heparin and dihydroergotamine.
    Bachner EJ; Konsens RM; Priem L; King T; Froimson AI
    Clin Orthop Relat Res; 1992 Oct; (283):261-4. PubMed ID: 1395256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ergotismus as a consequence of migraine prevention].
    Beck B; Daniel H
    Rofo; 1987 Apr; 146(4):470-3. PubMed ID: 3033778
    [No Abstract]   [Full Text] [Related]  

  • 27. Ergotism as complication of thromboembolic prophylaxis with heparin and dihydroergotamine.
    Gatterer R
    Lancet; 1986 Sep; 2(8507):638-9. PubMed ID: 2875358
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement].
    Kakkar VV; Bentley PG; Lawrence D; de Haas HA; Ward VP
    MMW Munch Med Wochenschr; 1979 Sep; 121(36):1152-4. PubMed ID: 114786
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of postoperative thromboembolism with a heparin- dihydroergotamine combination].
    Sándor T; Lászlo E; Magyary F; Turcsányi G; Hetényi L; Izinger E
    Orv Hetil; 1984 Feb; 125(9):519-24. PubMed ID: 6700990
    [No Abstract]   [Full Text] [Related]  

  • 30. [Venous tonus-modifying effect, pharmacokinetics and undesired effects of dihydroergotamine].
    Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):417-28. PubMed ID: 6390997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The problem of ergotism in thrombosis prevention with drugs].
    Räber G; Bauermeister U
    Z Arztl Fortbild (Jena); 1983; 77(23):965-8. PubMed ID: 6670300
    [No Abstract]   [Full Text] [Related]  

  • 32. [Postoperative thromboembolism prophylaxis with a reduced low dose heparin fraction and dihydroergotamine in fixed combination (author's transl)].
    Buttermann G; Haluszczynski I; Theisinger W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1213-6. PubMed ID: 6790966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ergotism and heparin-dihydroergotamine [letter].
    Kakkar VV
    Lancet; 1982 Jul; 2(8289):96-7. PubMed ID: 6123829
    [No Abstract]   [Full Text] [Related]  

  • 34. Dihydroergotamine and heparin or heparin alone for the prevention of postoperative thromboembolism in gynecology.
    Hohl MK; Lüscher KP; Annaheim M; Fridrich R; Gruber UF
    Arch Gynecol; 1980; 230(1):15-9. PubMed ID: 7436551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The value of heparin-dihydergot in the prevention of thromboembolic complications].
    Kuster B; Gruber UF
    Schweiz Med Wochenschr; 1984 Mar; 114(10):322-32. PubMed ID: 6369529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy-risk relationship in heparin-dihydroergotamine].
    Rasche H
    Dtsch Med Wochenschr; 1983 Jul; 108(26):1040-1. PubMed ID: 6851906
    [No Abstract]   [Full Text] [Related]  

  • 37. Ergotism as a consequence of thromboembolic prophylaxis.
    Ashenburg RJ; Phillips DA
    Radiology; 1989 Feb; 170(2):375-6. PubMed ID: 2911661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Perispinal anesthesia and subcutaneous administration of low-dose heparin-dihydergot for prevention of thromboembolism].
    Allemann BH; Gerber H; Gruber UF
    Anaesthesist; 1983 Feb; 32(2):80-3. PubMed ID: 6189414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of heparin in combination with dihydroergotamine for the postoperative prevention of thrombosis in hip joint surgery].
    Liedloff H; Brauckhoff KF; Heerdegen R; Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):428-31. PubMed ID: 6390998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Vasospastic reactions after heparin-dihydroergotamine].
    Paquet KJ
    Dtsch Med Wochenschr; 1982 Sep; 107(35):1333. PubMed ID: 7117143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.